Q3 2025 Management View Brian Carrico, President, CEO & Director, emphasized "the continued execution of our commercialization strategy for IB-Stim, our neuromodulation technology for both the ...

Neal K. Shah argues that a growing systemic failure to recover revenue in clinics is because growing claim denials are being treated as paperwork instead of actionable data. He says that artificial ...

Commercial-Grade Technology, Previously Limited to Pro and Collegiate Sports, Now Available with Smaller Footprint and ...

Q3 2025 Earnings Call Transcript November 13, 2025 Nyxoah S.A. misses on earnings expectations. Reported EPS is $-0.74 EPS, ...

IR uses the blood vessel network in the body as almost like a subway map. We can get on and off at different stops to access different parts of the body and treat disease. IR is the intersection of ...

Integrating Nym AI requires a clear plan that looks at both the technology and the people involved. By assessing current ...

New CPT code changes for invasive cardiology and interventional radiology will take effect on January 1, 2026, with a ...

New CPT code changes for invasive cardiology and interventional radiology will take effect on January 1, 2026, impacting a significant portion of hospital net revenue and threatening to exacerbate ...

BOSTON, Oct. 24, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., the makers of the Barricaid® Annular Closure Device, announced today that the American Medical Association (AMA) has published a new ...

AI medical device companies face major reimbursement hurdles when trying to secure coverage, CPT codes, and payment from ...

ZDNET sat down with Andrew Ng at AI Dev 25 in New York to talk about developer futures, responsible AI, and why AGI is overhyped.